A Study of PF-08634404 Alone and In Combination With Other Anticancer Drugs in People With Renal Cell Carcinoma

Full Title

An Interventional Phase 1b/2 Study to Evaluate the Safety And Efficacy of PF-08634404 Monotherapy and In Combination with Other Anticancer Agents In Adult Participants with Locally Advanced or Metastatic Renal Cell Carcinoma

Purpose

To learn more about the purpose of this study and to find out who can join, please click here to visit ClinicalTrials.gov for a full clinical trial description.

Contact

For more information or to see if you can join this study, please call Dr. Neil Shah’s office at 646-628-7505.